Cover Image


View/Hide Left Panel

McClead, R.E., and S.A.Gregory. 1984. Resistance of bovine colostral anti-cholera toxin antibody to in vitro and in vivo proteolysis. Infect. Immun. 44(2):474–478.

Mekalanos, J.J., D.J.Swartz, G.D.N.Pearson, N.Harford, F.Groyne, and M. de Wilde. 1983. Cholera toxin genes: Nucleotide sequence, deletion analysis, and vaccine development. Nature 306:551–557.

Miller, C.J., R.G.Feachem, and B.S.Drasar. 1985. Cholera epidemiology in developed and developing countries: New thoughts on transmission, seasonality, and control. Lancet I:261–263.

Minassian, D.C., V.Mehra, and B.R.Jones. 1984. Dehydrational crises from severe diarrhoea or heatstroke and risk of cataract. Lancet I:751–753.

New Scientist. 1986. New cholera vaccine will be tested on volunteers. New Scientist 109(1500):23.

Pierce, N.F., W.C.Cray, Jr., J.B.Sacci, Jr., J.P.Craig, R. Germanier, and E.Furer. 1983. Procholeragenoid: A safe and effective antigen for oral immunization against experimental cholera. Infect. Immun. 40(3):1112–1118.

Stock, R.F. 1976. Cholera in Africa. Diffusion of the Disease 1970–1975 with Particular Emphasis on West Africa. African Environmental Special Report 3. Plymouth, U.K.: Clarke, Doble & Brendon, Ltd.

Svennerholm, A.M. In press. Proceedings of Nobel Conference 11, Recent Advances in Vaccines and Drugs Against Diarrhoeal Diseases, Saltsjobaden, Stockholm, Sweden, June 3–6, 1985.

Svennerholm, A.M., M.Jertbon, L.Gothefors, A.Kavim, D.A.Sack, and J.Holmgren. 1983. Current status of an oral B subunit whole cell cholera vaccine. Dev. Biol. Stand. 53:73–79.

Woodward, W.E., R.Gilman, R.Hornick, J.Libonati, and R.Cash. 1976. Efficacy of a live oral cholera vaccine in human volunteers. Dev. Biol. Stand. 33:108–112.

World Health Organization. 1984. Cholera. Week. Epidemiol. Rec. 19: 141–142.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement